Skip to content

SCARP-DIAL (SGLT2i for CARdiovascular Protection in DIALysis)

Status
Not yet recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2026-526075-35-00
Enrollment
1000
Registered
2026-09-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease, Chronic dialysis

Brief summary

Time to first major adverse cardiovascular event (MACE) consisting of a composite of cardiovascular death, hospitalization or urgent visit for HF, myocardial infarction and ischemic stroke.

Detailed description

Total number of major cardiovascular events (MACE) consisting of a composite of cardiovascular death, hospitalization or urgent visit for HF, myocardial infarction and ischemic stroke, Time to first cardiovascular death or hospitalization or urgent visit for HF, Time to first all-cause hospitalization, Time to first hospitalization or urgent visit for HF, Time to cardiovascular death, Time to all-cause mortality, Change in symptom score according to Kansas City Cardiomyopathy Questionnaire (KCCQ-12), Change in recovery time after hemodialysis sessions (patient-reported), Time to first non-fatal myocardial infarction, Time to first non-fatal ischemic stroke, Time to first cardiac revascularizations, Time to first new onset atrial fibrillation/flutter

Interventions

DRUGDAPAGLIFLOZIN

Sponsors

Karolinska University Hospital
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Time to first major adverse cardiovascular event (MACE) consisting of a composite of cardiovascular death, hospitalization or urgent visit for HF, myocardial infarction and ischemic stroke.

Secondary

MeasureTime frame
Total number of major cardiovascular events (MACE) consisting of a composite of cardiovascular death, hospitalization or urgent visit for HF, myocardial infarction and ischemic stroke, Time to first cardiovascular death or hospitalization or urgent visit for HF, Time to first all-cause hospitalization, Time to first hospitalization or urgent visit for HF, Time to cardiovascular death, Time to all-cause mortality, Change in symptom score according to Kansas City Cardiomyopathy Questionnaire (KCCQ-12), Change in recovery time after hemodialysis sessions (patient-reported), Time to first non-fatal myocardial infarction, Time to first non-fatal ischemic stroke, Time to first cardiac revascularizations, Time to first new onset atrial fibrillation/flutter

Outcome results

None listed

Source: EU CTIS · Data processed: Sep 11, 2026